Professor Yoni Freedhoff claimed that changing eating and exercise habits will never be as effective as weight-loss drugs ...

A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Azealia Banks made explosive allegations against Elon Musk during a tirade aimed at Musk’s ex Grimes, criticizing his past ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...